Tag: capital
-
Washington, California sue over pelvic mesh implants
SEATTLE (AP) — Washington state and California sued Johnson & Johnson on Tuesday, saying that for years the company misrepresented the risks of vaginal mesh implants it sold to repair pelvic collapse.
-
UniQure shares jump on promising gene therapy data
Dutch biotech UniQure NV said its experimental gene therapy for a blood disorder benefited some patients in an early-stage study, offering a rare ray of hope in gene therapy research plagued by a series of failed trials. Janney Capital Markets analyst Debjit Chattopadhyay said UniQure’s data looked better than that of Baxalta Inc’s rival drug.…
-
Ukraine health system in danger of collapse as reforms stall
A reform drive launched by the Western-leaning government installed after a pro-Moscow president, Viktor Yanukovich, was overthrown in a popular uprising last year has become mired in bureaucratic inertia, arguments and allegations of corruption. “I don't know who is writing and carrying out reforms at the top or if they have ever been to a…
-
Sanofi submits new diabetes drug application to U.S. regulator
French drugmaker Sanofi said on Wednesday it had submitted an application to the U.S. Food and Drug Administration (FDA) for a single daily insulin injection to treat adults with type 2 diabetes. Sanofi said it had requested a six-month review of its new drug application by the FDA, rather than the standard 10 months. “A…
-
Valeant, Ackman must face U.S. insider trading lawsuit
A U.S. judge said Valeant Pharmaceuticals International Inc and activist hedge fund manager William Ackman must face a lawsuit accusing them of insider trading in Allergan Inc before making an unsuccessful takeover bid for the maker of Botox. In a Nov. 9 decision, U.S. District Judge David Carter in Santa Ana, California, rejected arguments by…